283 related articles for article (PubMed ID: 17000001)
1. An apparent paradox: chemokine receptor agonists can be used for anti-inflammatory therapy.
Ali S; O'Boyle G; Mellor P; Kirby JA
Mol Immunol; 2007 Mar; 44(7):1477-82. PubMed ID: 17000001
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory drug development: Broad or specific chemokine receptor antagonists?
Russo RC; Garcia CC; Teixeira MM
Curr Opin Drug Discov Devel; 2010 Jul; 13(4):414-27. PubMed ID: 20597027
[TBL] [Abstract][Full Text] [Related]
3. [Chemokines a hope of specific anti-inflammatory treatment].
Schedvins P; Hjelmström P
Lakartidningen; 2002 Mar; 99(10):1056-9. PubMed ID: 12024779
[TBL] [Abstract][Full Text] [Related]
4. Chemokine sequestration by atypical chemokine receptors.
Hansell CA; Simpson CV; Nibbs RJ
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1009-13. PubMed ID: 17073739
[TBL] [Abstract][Full Text] [Related]
5. Relationships between glycosaminoglycan and receptor binding sites in chemokines-the CXCL12 example.
Laguri C; Arenzana-Seisdedos F; Lortat-Jacob H
Carbohydr Res; 2008 Aug; 343(12):2018-23. PubMed ID: 18334249
[TBL] [Abstract][Full Text] [Related]
6. Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease.
Donnelly LE; Barnes PJ
Trends Pharmacol Sci; 2006 Oct; 27(10):546-53. PubMed ID: 16911834
[TBL] [Abstract][Full Text] [Related]
7. Interfering with chemokine networks--the hope for new therapeutics.
Schwarz MK; Wells TN
Curr Opin Chem Biol; 1999 Aug; 3(4):407-17. PubMed ID: 10419853
[TBL] [Abstract][Full Text] [Related]
8. Chemokine-receptor interactions: GPCRs, glycosaminoglycans and viral chemokine binding proteins.
Lau EK; Allen S; Hsu AR; Handel TM
Adv Protein Chem; 2004; 68():351-91. PubMed ID: 15500866
[TBL] [Abstract][Full Text] [Related]
9. [Chemokines, a new family of cytokines in inflammatory cell recruitment].
Martínez Martínez CM; Hernández Pando R
Rev Invest Clin; 1999; 51(4):255-68. PubMed ID: 10546507
[TBL] [Abstract][Full Text] [Related]
10. The chemokine family. Potential therapeutic targets from allergy to HIV infection.
Proudfoot AE
Eur J Dermatol; 1998; 8(3):147-57. PubMed ID: 9649701
[TBL] [Abstract][Full Text] [Related]
11. Anti-chemokine small molecule drugs: a promising future?
Proudfoot AE; Power CA; Schwarz MK
Expert Opin Investig Drugs; 2010 Mar; 19(3):345-55. PubMed ID: 20113217
[TBL] [Abstract][Full Text] [Related]
12. Chemokines in transplantation: what can atypical receptors teach us about anti-inflammatory therapy?
O'Boyle G; Ali S; Kirby JA
Transplant Rev (Orlando); 2011 Oct; 25(4):136-44. PubMed ID: 21514134
[TBL] [Abstract][Full Text] [Related]
13. Chemokines and their receptors: orchestrating a fine balance between health and disease.
Sharma M
Crit Rev Biotechnol; 2010 Mar; 30(1):1-22. PubMed ID: 19780653
[TBL] [Abstract][Full Text] [Related]
14. Post-translational control of chemokines: a role for decoy receptors?
Comerford I; Nibbs RJ
Immunol Lett; 2005 Jan; 96(2):163-74. PubMed ID: 15585320
[TBL] [Abstract][Full Text] [Related]
15. Targeting the chemokine network in renal inflammation.
Eis V; Vielhauer V; Anders HJ
Arch Immunol Ther Exp (Warsz); 2004; 52(3):164-72. PubMed ID: 15247883
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic inhibition of leukocyte recruitment in inflammatory diseases.
Szekanecz Z; Koch AE
Curr Opin Pharmacol; 2004 Aug; 4(4):423-8. PubMed ID: 15251139
[TBL] [Abstract][Full Text] [Related]
17. Agonistic and antagonistic activities of chemokines.
Loetscher P; Clark-Lewis I
J Leukoc Biol; 2001 Jun; 69(6):881-4. PubMed ID: 11404371
[TBL] [Abstract][Full Text] [Related]
18. Unravelling the mechanisms underpinning chemokine receptor activation and blockade by small molecules: a fine line between agonism and antagonism?
Wise E; Pease JE
Biochem Soc Trans; 2007 Aug; 35(Pt 4):755-9. PubMed ID: 17635141
[TBL] [Abstract][Full Text] [Related]
19. Professional and part-time chemokine decoys in the resolution of inflammation.
Hansell C; Nibbs R
Sci STKE; 2007 May; 2007(384):pe18. PubMed ID: 17473307
[TBL] [Abstract][Full Text] [Related]
20. CXCR2--the receptor to hit?
Reutershan J
Drug News Perspect; 2006 Dec; 19(10):615-23. PubMed ID: 17299604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
